Skip to main navigation menu Skip to main content Skip to site footer

Editorial

Editorial



Open | Download

How to Cite

1.
Ortiz Gómez LD. Editorial. Rev. colomb. hematol. oncol. [Internet]. 2025 Jun. 27 [cited 2025 Dec. 5];12(1):10-3. https://doi.org/10.51643/22562915.786

Download Citation

Citations


Section
Editorial

How to Cite
1.
Ortiz Gómez LD. Editorial. Rev. colomb. hematol. oncol. [Internet]. 2025 Jun. 27 [cited 2025 Dec. 5];12(1):10-3. https://doi.org/10.51643/22562915.786

Dimensions
PlumX


Article visits 184 | PDF visits 181


Downloads

Download data is not yet available.
  1. Martínez CH, Dave S, Izawa J. Wilms’ tumor. Adv Exp Med Biol [Internet]. 2010;685:196-209. PMID: 20687507 Disponible en: https://pubmed.ncbi.nlm.nih.gov/20687507/ DOI: https://doi.org/10.1007/978-1-4419-6448-9_18
  2. Friedman AD. Wilms Tumor. Pediatr Rev [Internet]. 2013 Jul 1;34(7):328-30. Disponible en: https://doi.org/10.1542/pir.34-7-328 DOI: https://doi.org/10.1542/pir.34.7.328
  3. Spreafico F, Fernandez CV, Brok J, Nakata K, Vujanic G, Geller JI, et al. Wilms tumour. Nat Rev Dis Primer [Internet]. 2021 Oct 14;7(1):75. Disponible en: https://doi.org/10.1038/s41572-021-00308-8. DOI: https://doi.org/10.1038/s41572-021-00308-8
  4. Ataseven B, Frindte J, Harter P, Gebers G, Vogt C, Traut A, et al. Perception of side effects associated with anticancer treatment in women with breast or ovarian cancer (KEM-GO-1): a prospective trial. Support Care Cancer Off J Multinatl Assoc Support Care Cancer [Internet]. 2020 Aug;28(8):3605-15. Disponible en: https://doi.org/10.1007/s00520-019-05216-y. DOI: https://doi.org/10.1007/s00520-019-05216-y
  5. Prieto-Callejero B, Rivera F, Fagundo-Rivera J, Romero A, Romero-Martín M, Gómez-Salgado J, et al. Relationship between chemotherapy-induced adverse reactions and health-related quality of life in patients with breast cancer. Medicine (Baltimore) [Internet]. 2020 Aug 14;99(33):e21695. Disponible en: http://dx.doi.org/10.1097/MD.0000000000021695 DOI: https://doi.org/10.1097/MD.0000000000021695
  6. Assi S, Torrington E, Cheema E, Hamid AA. Adverse drug reactions associated with chemotherapeutic agents used in breast cancer: Analysis of patients’ online forums. J Oncol Pharm Pract [Internet]. 2021 Jan;27(1):108-18. Disponible en: https://doi.org/10.1177/1078155220915767 DOI: https://doi.org/10.1177/1078155220915767
  7. Ezigbo E, Ukaejiofo E, Nwagha T. Molecular characterization of exon 28 of von Willebrand’s factor gene in Nigerian population. Niger J Clin Pract [Internet]. 2017;20(2):235. Disponible en: https://doi.org/10.4103/1119-3077.197002. DOI: https://doi.org/10.4103/1119-3077.197002
  8. Donnér M, Holmberg L, Kristoffersson A, Nilsson IM. An HphI‐polymorphism in exon 28 of the von Willebrand factor gene, and its frequency among patients with various forms of von Willebrand’s disease. Br J Haematol [Internet]. 1991 Jul;78(3):403-7. Disponible en: https://doi.org/10.1111/j.1365-2141.1991.tb04455.x. DOI: https://doi.org/10.1111/j.1365-2141.1991.tb04455.x
  9. Satoh Y, Kita H, Kihira K, Mutoh H, Osawa H, Satoh K, et al. Gastrointestinal Angiodysplasia in a Patient with Type 2 von Willebrand’s Disease and Analysis of Exon 28 of the von Willebrand Factor Gene. Am J Gastroenterol [Internet]. 2004 Dec;99(12):2495-8. Disponible en: https://doi.org/10.1111/j.1572-0241.2004.40459.x. DOI: https://doi.org/10.1111/j.1572-0241.2004.40459.x
  10. Li W, Gonzalez-Gonzalez M, Sanz-Criado L, Garcia-Carbonero N, Celdran A, Villarejo-Campos P, et al. A Novel PiRNA Enhances CA19-9 Sensitivity for Pancreatic Cancer Identification by Liquid Biopsy. J Clin Med [Internet]. 2022 Dec 9;11(24):7310. Disponible en: https://doi.org/10.3390/jcm11247310. DOI: https://doi.org/10.3390/jcm11247310
  11. Xie J, Xing S, Shen BY, Chen HT, Sun B, Wang ZT, et al. PIWIL1 interacting RNA piR-017061 inhibits pancreatic cancer growth via regulating EFNA5. Hum Cell [Internet]. 2021 Mar;34(2):550-63. Disponible en: https://doi.org/10.1007/s13577-020-00463-2. DOI: https://doi.org/10.1007/s13577-020-00463-2
  12. Zhong Y, Tian Y, Wang Y, Bai J, Long Q, Yan L, et al. Small Extracellular Vesicle piR-hsa-30937 Derived from Pancreatic Neuroendocrine Neoplasms Upregulates CD276 in Macrophages to Promote Immune Evasion. Cancer Immunol Res [Internet]. 2024 Jul 2;12(7):840-53. Disponible en: https://doi.org/10.1158/2326-6066.CIR-23-0825. DOI: https://doi.org/10.1158/2326-6066.CIR-23-0825
  13. Wang R, Chen C, Kang W, Meng G. SNHG9 was upregulated in NSCLC and associated with DDP-resistance and poor prognosis of NSCLC patients. Am J Transl Res [Internet]. 2020;12(8):4456-66. PMID: 32913519 Disponible en: https://pubmed.ncbi.nlm.nih.gov/32913519/
  14. Wang D, Cao X, Han Y, Yu D. LncRNA SNHG9 is Downregulated in Non-Small Cell Lung Cancer and Suppressed miR-21 Through Methylation to Promote Cell Proliferation. Cancer Manag Res [Internet]. 2020 Aug;12:7941-8. Disponible en: https://doi.org/10.2147/CMAR.S253052 DOI: https://doi.org/10.2147/CMAR.S253052
  15. Li J, Wang N, Zhang F, Jin S, Dong Y, Dong X, et al. PIWI ‐interacting RNAs are aberrantly expressed and may serve as novel biomarkers for diagnosis of lung adenocarcinoma. Thorac Cancer [Internet]. 2021 Sep;12(18):2468-77. Disponible en: https://doi.org/10.1111/1759-7714.14094 DOI: https://doi.org/10.1111/1759-7714.14094
Sistema OJS 3.4.0.7 - Metabiblioteca |